Neumega Lyophilisate For Solution For Injection 5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Neumega: Lyophilisate for solution for injection (5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

OPRELVEKIN (oh PREL ve kin) helps your body make more platelets in the blood. It is used to prevent low platelet counts after chemotherapy.

In-Depth Information

Neumega 5mg Powder for Injection

NDC: 583940004
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Chemotherapy-induced Thrombocytopenia

Storage Information
Protect from light
Do not freeze
Store between 36 to 46 degrees F
Neumega 5mg Powder for Injection

Reported Side Effects for Neumega 5mg Powder for Injection

Low Potassium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Antibody Formation Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Optic Disc Swelling Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Bruise Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
>10.0%*
Severity: MILD
Onset: RAPID
Hair Loss Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Fluid Around The Lungs Incidence:
10.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
10.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Bone Pain Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Irregular Heart Beat Incidence:
12.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Rate Incidence:
12.0%*
Severity: SEVERE
Onset: EARLY
Fainting Incidence:
13.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
14.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
14.0%*
Severity: MODERATE
Onset: EARLY
Yeast Infection Incidence:
14.0%*
Severity: MODERATE
Onset: DELAYED
Eye Infection Incidence:
19.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
20.0%*
Severity: MODERATE
Onset: RAPID
Skin Rash Incidence:
25.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
25.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
29.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
33.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
38.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
41.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
42.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
43.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
43.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
48.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
59.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
77.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
77.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Neumega

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5